Delivery Order SPE2DB22D3016-SPE2DB24FBGV5

Award Date 9/13/24
Potential Completion Date 9/16/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $1,440.12 to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of 4,564,478,208 units of Glucagon 1 mg Emergency Kits, with a completion date of May 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The U.S. Defense Logistics Agency (DLA) awarded a $1,858.44 delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Glucagon 1 mg emergency kits. This contract is a firm-fixed price delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distributor, to provide 4,563,756,316 Glucagon 1 mg emergency kits. The total potential value of the award is $2,729.14. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver...
The U.S. government awarded a $3,806.26 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of 4,560,593,607 units of GLUCAGON 1 MG EMERGENCY KITS. The contract has an ultimate completion date of April 17, 2023 and does not utilize any set-aside requirements. Amerisourcebergen holds a $999,999,999...
This federal contract award, valued at $4,539.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLUCAGON 1 MG EMERGENCY KITS, with a performance period through April 2, 2024. The contract is a Delivery Order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
The Defense Logistics Agency (DLA) awarded a $2,600.34 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,881,114 units of Glucagon 1 mg emergency kits. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award, valued at $2,686.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLUCAGON 1 MG EMERGENCY KITS, a critical medical commodity used in the treatment of medical emergencies. The contract has an ultimate completion date of February 12, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for GLUCAGON 1 MG EMERGENCY KITS. The contract has a firm fixed price of $1,602.38 and a completion date of March 10, 2025. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLUCAGON 1 MG EMERGENCY KITS, with a ceiling value of $3,975.78 and a completion date of March 17, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,161,248 Glucagon 1 mg Emergency Kits. The contract has an ultimate completion date of April 4, 2024 and a ceiling value of $4,634.40. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBGV5
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $11,184.89 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565805348 - GLUCAGON 1 MG EMERGENCY KITS. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and the ultimate completion date is September 16, 2024.

Generated 12/13/24, 9:23 AM